Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1988 Jan;63(1):93–97.

Modulation of natural killing by cyclo- and lipo-oxygenase inhibitors.

M L Villa 1, F Valenti 1, M Mantovani 1
PMCID: PMC1454712  PMID: 3123373

Abstract

The effect on NK activity of two oxygenase inhibitors, indomethacin which is cyclo-oxygenase-specific at 10(-6) M and BW755C which blocks both cyclo- and lipo-oxygenase, has been analysed. The NK activity of human peripheral blood mononuclear cells (PBMC) has been studied in a 18-hr 51Cr-release assay. PBMC were incubated with the drugs for different periods of time before and during NK assay in order to analyse the correlations between the time of incubation and the modulation of NK activity. The results show that the inhibition of the cyclo-oxygenase alone, by indomethacin, enhances the NK activity if the drug is added both during and prior to the assay. In the latter case the enhancement is time dependent, reaching a maximum level after 18 hr of incubation. The simultaneous inhibition of lipo- and cyclo-oxygenase by BW755C has a rather more complex effect. The NK activity is similar to that of untreated cells after 6 hr incubation with BW755C, but is inhibited or greatly enhanced after 4 and 18 hr of incubation, respectively. These effects seem largely independent of the presence of monocytes because they can be observed with non-adherent PBMC (NA-PBMC).

Full text

PDF
93

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carine K., Hudig D. Assessment of a role for phospholipase A2 and arachidonic acid metabolism in human lymphocyte natural cytotoxicity. Cell Immunol. 1984 Aug;87(1):270–283. doi: 10.1016/0008-8749(84)90151-5. [DOI] [PubMed] [Google Scholar]
  2. Droller M. J., Schneider M. U., Perlmann P. A possible role of prostaglandins in the inhibition of natural and antibody-dependent cell-mediated cytotoxicity against tumor cells. Cell Immunol. 1978 Aug;39(1):165–177. doi: 10.1016/0008-8749(78)90091-6. [DOI] [PubMed] [Google Scholar]
  3. Ellis N. K., Young M. R., Nikcevich D. A., Newby M., Plioplys R., Wepsic H. T. Stimulation of prostaglandin-dependent macrophage suppressor cells by the subcutaneous injection of polyunsaturated fatty acids. Cell Immunol. 1986 Oct 15;102(2):251–260. doi: 10.1016/0008-8749(86)90419-3. [DOI] [PubMed] [Google Scholar]
  4. Fischer D. G., Hubbard W. J., Koren H. S. Tumor cell killing by freshly isolated peripheral blood monocytes. Cell Immunol. 1981 Mar 1;58(2):426–435. doi: 10.1016/0008-8749(81)90235-5. [DOI] [PubMed] [Google Scholar]
  5. Goodwin J. S., Ceuppens J. Regulation of the immune response by prostaglandins. J Clin Immunol. 1983 Oct;3(4):295–315. doi: 10.1007/BF00915791. [DOI] [PubMed] [Google Scholar]
  6. Henney C. S. Quantitation of the cell-mediated immune response. I. The number of cytolytically active mouse lymphoid cells induced by immunization with allogeneic mastocytoma cells. J Immunol. 1971 Dec;107(6):1558–1566. [PubMed] [Google Scholar]
  7. Jondal M., Kullman C., Rossi P., Lindgren J. A. Second messenger function of arachidonic acid lipoxygenation products in human natural killer cell lysis? Scand J Immunol. 1985 Sep;22(3):285–293. doi: 10.1111/j.1365-3083.1985.tb01883.x. [DOI] [PubMed] [Google Scholar]
  8. Kendall R. A., Targan S. The dual effect of prostaglandin (PGE2) and ethanol on the natural killer cytolytic process: effector activation and NK-cell-target cell conjugate lytic inhibition. J Immunol. 1980 Dec;125(6):2770–2777. [PubMed] [Google Scholar]
  9. Koren H. S., Anderson S. J., Fischer D. G., Copeland C. S., Jensen P. J. Regulation of human natural killing. I. The role of monocytes, interferon, and prostaglandins. J Immunol. 1981 Nov;127(5):2007–2013. [PubMed] [Google Scholar]
  10. Leung K. H., Ip M. M., Koren H. S. Regulation of human natural killing. IV. Role of lipoxygenase in regulation of natural killing activity. Scand J Immunol. 1986 Oct;24(4):371–380. doi: 10.1111/j.1365-3083.1986.tb02124.x. [DOI] [PubMed] [Google Scholar]
  11. Leung K. H., Ip M. M. Regulation of rat natural killing. II. Inhibition of cytolysis and activation by inhibitors of lipoxygenase: possible role of leukotrienes. Cell Immunol. 1986 Jul;100(2):474–484. doi: 10.1016/0008-8749(86)90046-8. [DOI] [PubMed] [Google Scholar]
  12. Leung K. H., Mihich E. Effects of prostaglandins on the development of cell-mediated immunity in culture and on the cytolytic activity of in vivo-generated effector cells. Int J Immunopharmacol. 1982;4(3):205–217. doi: 10.1016/0192-0561(82)90050-9. [DOI] [PubMed] [Google Scholar]
  13. Li C. Y., Lam K. W., Yam L. T. Esterases in human leukocytes. J Histochem Cytochem. 1973 Jan;21(1):1–12. doi: 10.1177/21.1.1. [DOI] [PubMed] [Google Scholar]
  14. Rossi P., Lindgren J. A., Kullman C., Jondal M. Products of the lipoxygenase pathway in human natural killer cell cytotoxicity. Cell Immunol. 1985 Jun;93(1):1–8. doi: 10.1016/0008-8749(85)90383-1. [DOI] [PubMed] [Google Scholar]
  15. Sibbitt W. L., Jr, Imir T., Bankhurst A. D. Reversible inhibition of lymphokine-activated killer cell activity by lipoxygenase-pathway inhibitors. Int J Cancer. 1986 Oct 15;38(4):517–521. doi: 10.1002/ijc.2910380411. [DOI] [PubMed] [Google Scholar]
  16. Villa M. L., Rappocciolo G., Piazza P. Primary in vitro antibody response in humans: role of adherent cells in the development of haemolytic colonies. Immunology. 1986 Aug;58(4):569–575. [PMC free article] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES